ArticleJACC. Case reports2026
Fatal Prosthetic Valve Endocarditis After Transcatheter Tricuspid Valve Replacement: Specialist Cardiac Autopsy Findings.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTranscatheter tricuspid valve replacement (TTVR) is an emerging therapy for severe tricuspid regurgitation with an evolving complication profile. Fatal prosthetic valve endocarditis (PVE) following orthotopic TTVR appears exceptionally rare, with detailed pathologic description through specialist cardiovascular autopsy remaining limited. CASE SUMMARY: A 65-year-old man with severe functional tricuspid regurgitation and persistent atrial fibrillation underwent TTVR. The following day, he developed complete heart block requiring pacemaker implantation. He remained well at 1 and 3 months, with improving symptoms and unremarkable bloods. At 6 months, he developed nonspecific viral-like symptoms over 48 hours culminating in death at home. Routine postmortem examination attributed death to coronary artery disease. Specialist cardiovascular pathology demonstrated PVE with large vegetations, atrioventricular nodal obliteration, left atrial communication enabling systemic septic embolization, diffuse coronary microembolization, and widespread left ventricular microabscesses. DISCUSSION: Fatal PVE after TTVR may present with nonspecific prodromal symptoms. Unexplained death after transcatheter valve intervention warrants specialist cardiovascular pathology. TAKE HOME MESSAGE: Prosthetic valve endocarditis after transcatheter tricuspid valve replacement may present with nonspecific symptoms and rapid clinical deterioration; unexplained death should prompt specialist cardiovascular pathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.